Early Life-Stage Toxicity of Eight Pharmaceuticals to the Fathead Minnow, Pimephales promelas
- 4 November 2011
- journal article
- research article
- Published by Springer Nature in Archives of Environmental Contamination and Toxicology
- Vol. 62 (3) , 455-464
Abstract
Human pharmaceuticals are routinely being detected in the environment, and there is growing concern about whether these drugs could elicit effects on aquatic organisms. Regulatory paradigms have shifted accordingly, with a greater emphasis on chronic toxicity data compared with acute data. The Organisation for Economic Co-operation and Development 210 Early Life Stage Test has been proposed as a good measure of the potential for pharmaceuticals to elicit chronic toxicity. To begin building a data set regarding the early life-stage toxicity of pharmaceuticals to fish, fathead minnows (FHM) were exposed to amiodarone, carbamazepine, clozapine, dexamethasone, fenofibrate, ibuprofen, norethindrone, or verapamil. Survival and growth were used to assess chronic toxicity in FHM at 28 days posthatch. Exposure of FHM to carbamazepine, fenofibrate, and ibuprofen resulted in no significant adverse effects at the concentrations tested. FHM survival was not impacted by verapamil exposure; however, growth was significantly decreased at 600 μg/L. Dexamethasone-exposed FHM showed a significant decrease in survival at a concentration of 577 μg/L; however, growth was not impacted at the concentration tested. Norethindrone exposure resulted in a significant decrease in survival and dry weight at 14.8 and 0.74 μg/L, respectively. Exposure to amiodarone and clozapine resulted in a significant decrease in survival and a significant increase in growth at concentrations of 1020 and 30.8 μg/L, respectively. Although the effect levels derived in this study are greater then concentrations observed in the environment, these data suggest that synthetic progestins may require additional research.Keywords
This publication has 58 references indexed in Scilit:
- Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewaterWater Research, 2011
- Association of Weight Gain and Metabolic Syndrome in Patients Taking ClozapineThe Journal of Clinical Psychiatry, 2010
- Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography–tandem mass spectrometry assayJournal of Pharmaceutical and Biomedical Analysis, 2010
- Human pharmaceuticals in surface watersToxicology Letters, 2008
- Collapse of a fish population after exposure to a synthetic estrogenProceedings of the National Academy of Sciences, 2007
- Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closureBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Effects of the synthetic estrogen 17α-ethinylestradiol on the life-cycle of the fathead minnow (Pimephales promelas)Environmental Toxicology and Chemistry, 2001
- Steroid-Induced Sex Determination at Incubation Temperatures Producing Mixed Sex Ratios in a Turtle with TSDGeneral and Comparative Endocrinology, 1995
- A report on methods to reduce, refine and replace animal testing in industrial toxicology laboratoriesCell Biology and Toxicology, 1989
- Teratogenic Effects of Some Calcium Channel Blocking Agents in Xenopus EmbryosBasic & Clinical Pharmacology & Toxicology, 1989